Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-CLOBETASOL SCALP APPLICATION MYLAN PHARMACEUTICALS ULC Actual shortage 0.05% Updated Report 2025-04-23 255039
OMNIPAQUE 350 GE HEALTHCARE CANADA INC Actual shortage 755MG Updated Report 2025-04-23 255396
MYLAN-PROPAFENONE MYLAN PHARMACEUTICALS ULC Actual shortage 150MG Updated Report 2025-04-23 253696
KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD. Actual shortage 12MG Updated Report 2025-04-22 212529
SANDOZ FENOFIBRATE E SANDOZ CANADA INCORPORATED Actual shortage 145.0MG New Report 2025-04-22 255391
SUPEUDOL 5 SANDOZ CANADA INCORPORATED Actual shortage 5MG Updated Report 2025-04-22 238345
SUPEUDOL 10 SANDOZ CANADA INCORPORATED Actual shortage 10MG Updated Report 2025-04-22 238341
SANDOZ RIVAROXABAN SANDOZ CANADA INCORPORATED Actual shortage 2.5MG Updated Report 2025-04-22 245211
SANDOZ LOSARTAN HCT SANDOZ CANADA INCORPORATED Actual shortage 12.5MG 100MG Updated Report 2025-04-22 251581
SANDOZ IRBESARTAN SANDOZ CANADA INCORPORATED Actual shortage 150MG Updated Report 2025-04-22 248132

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
HYPURIN REGULAR INSULIN PORK WOCKHARDT UK LIMITED To be discontinued 100UNIT New Report 2025-04-17 255200
HYPURIN NPH INSULIN ISOPHANE PORK WOCKHARDT UK LIMITED To be discontinued 100UNIT New Report 2025-04-17 255197
PRADAXA BOEHRINGER INGELHEIM (CANADA) LTD LTEE To be discontinued 75MG New Report 2025-04-17 255171
PROTOPIC LEO PHARMA INC Discontinued 0.03% Updated Report 2025-04-16 255091
PROTOPIC LEO PHARMA INC Discontinued 0.1% Updated Report 2025-04-16 255094